Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike | medRxiv
The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis | PLOS Pathogens
![Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540)](https://www.abcam.com/ps/products/259/ab259540/Images/ab259540-1-benefits-of-recombinant-antibodies.png "Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540)")
Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540)
Cross-reactivity of Antibody: Beneficial or Harmful? - Cusabio
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine
Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality
Viruses | Free Full-Text | Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
One-Step Identification of Antibody Degradation Pathways Using Fluorescence Signatures Generated by Cross-Reactive DNA-Based Arrays | Analytical Chemistry
Frontiers | Cross-Reactive Immunity Among Flaviviruses
pHAb Reactive Dyes
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine
Cross-reactive anti-CCD antibodies can hinder allergy diagnostics - EUROIMMUNBlog
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
Change Calculated Panel Reactive Antibody (CPRA) Calculation - OPTN
Remembering seasonal coronaviruses | Science
How to Determine Antibody Cross-Reactivity | Boster Bio
pHAb Reactive Dyes
Human C-Reactive Protein/CRP Antibody AF1707: R&D Systems
Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell
Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus and Impact of 2010–11 Seasonal Influenza Vaccine on Cross-Reactive Antibodies — United States
Human C-Reactive Protein/CRP Antibody MAB17072-100: R&D Systems
Redemption for self-reactive antibodies | Science
